Healthcare, Communication Aug 31, 2021 04:56 PM (GMT+8) · EqualOcean
Financial Associated Press, August 31 - Junshi biology announced that recently, the company received the notice of approval of drug clinical trial approved and issued by the State Drug Administration. After review, js014 injection accepted on June 24, 2021 met the relevant requirements of drug registration and agreed to carry out the clinical trial of advanced malignant tumors.
Related companies: